229 Discussion 33. Pranckeviciene A, Deltuva VP, Tamasauskas A, et al. Association between psychological distress, subjective cognitive complaints and objective neuropsychological functioning in brain tumor patients. Clin Neurol Neurosurg 2017; 163: 18–23. 34. Poppelreuter M, Weis J, Külz AK, et al. Cognitive dysfunction and subjective complaints of cancer patients: A cross-sectional study in a cancer rehabilitation centre. Eur J Cancer 2004; 40: 43–49. 35. Pinkham MB, Whitfield GA, Brada M. New developments in intracranial stereotactic radiotherapy for metastases. Clin Oncol 2015; 27: 316–323. 36. Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): A multi-institutional prospective observational study. Lancet Oncol 2014; 15: 387–395. 37. Soliman H, Das S, Larson DA, et al. Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases. Oncotarget 2016; 7: 12318– 12330. 38. Federatie Medisch Specialisten. Hersenmetastasen Behandelrichtlijn. 2020. 39. McKay WH, McTyre ER, Okoukoni C, et al. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg 2017; 127: 148–156. 40. Minniti G, Scaringi C, Paolini S, et al. Repeated stereotactic radiosurgery for patients with progressive brain metastases. J Neurooncol 2016; 126: 91–97. 41. Koffer P, Chan J, Rava P, et al. Repeat Stereotactic Radiosurgery for Locally Recurrent Brain Metastases. World Neurosurg 2017; 104: 589–593. 42. Fritz C, Borsky K, Stark LS, et al. Repeated courses of radiosurgery for new brain metastases to defer whole brain radiotherapy: Feasibility and outcome with validation of the new prognostic metric brain metastasis velocity. Front Oncol; 8. Epub ahead of print 2018. DOI: 10.3389/fonc.2018.00551. 43. Shultz DB, Modlin LA, Jayachandran P, et al. Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases after Initial SRS. Int J Radiat Oncol Biol Phys 2015; 92: 993–999. 44. Lee WJ, Choi JW, Kong DS, et al. Clinical outcomes of patients with multiple courses of radiosurgery for brain metastases from non-small cell lung cancer. Sci Rep; 12. Epub ahead of print 1 December 2022. DOI: 10.1038/s41598-02213853-3. 45. Stern Y, Arenaza-Urquijo EM, Bartrés-Faz D, et al. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimer’s and Dementia 2020; 16: 1305–1311. 46. Jacobson NS, Roberts LJ, Berns SB, et al. Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives. J Consult Clin Psychol 1999; 67: 300–307. 47. Jacobson NS, Truax P. Clinical Significance: A Statistical Approach to Denning Meaningful Change in Psychotherapy Research. Journal of Consulting and Clinical Psychologv 1991; 59: 12–19. 48. Dengel DR, Evanoff NG, Marlatt KL, et al. Reproducibility of blood oxygen leveldependent signal changes with end-tidal carbon dioxide alterations. Clin Physiol Funct Imaging 2017; 37: 794–798. 49. Feenstra HEM, Murre JMJ, Vermeulen IE, et al. Reliability and validity of a selfadministered tool for online neuropsychological testing: The Amsterdam Cognition Scan. J Clin Exp Neuropsychol 2018; 40: 253–273. 9
RkJQdWJsaXNoZXIy MTk4NDMw